What is the Fiscal Year for argenx?
Date: November 14, 2026
argenx's current fiscal year starts on January 1, 2026, and ends on December 31, 2026. Their current quarter is Q4, which ends on December 31, 2026.
Current Fiscal Year Overview
Fiscal Year Start
January 1, 2026
Fiscal Year End
December 31, 2026
Current Quarter
Q4
Current Quarter End
December 31, 2026
Quarterly Breakdown
Q1
Jan 1, 2026 – Mar 31, 2026
Q2
Apr 1, 2026 – Jun 30, 2026
Q3
Jul 1, 2026 – Sep 30, 2026
Q4
Oct 1, 2026 – Dec 31, 2026
Company Information
Headquarters
Boston, MA
Industry
Biotechnology Research
Stock Symbol
ARGX
Website
http://www.argenx.comDescription
As the immunology innovation company, argenx develops first-in-class medicines that change the course of disease and set a new direction for patients waiting for a breakthrough. Entrepreneurial Science shapes how we work: challenging conventions, pursuing bold pathways over conventional ones through the power of co-creation, and working alongside scientists, physicians and academic researchers with shared ambition — changing outcomes. Our purpose is to move immunology science faster than thought possible for patients who need progress now.
Use Salesmotion for Account Data and Insights
Sales professionals can use Salesmotion to access comprehensive account intelligence and automate their research. Instantly get insights on companies like argenx and uncover key business information that drives smarter conversations.
Book a demo today to strengthen your sales strategy with powerful data and actionable insights.